| Brandon L Kovar, MD | |
|
1614 Diamond Street Pl, Onawa, IA 51040-1554 | |
| (712) 423-1525 | |
| (712) 423-2528 |
| Full Name | Brandon L Kovar |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 17 Years |
| Location | 1614 Diamond Street Pl, Onawa, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154529725 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 38821 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Burgess Home Health | Onawa, IA | Home health agency |
| Burgess Hospice | Onawa, IA | Hospice |
| Burgess Health Center | Onawa, IA | Hospital |
| Pleasant View Care Center | Whiting, IA | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Burgess Health Center | 0143131516 | 10 |
| Family Medicine Clinic, P.c. | 0547159824 | 6 |
News Archive
A combination of two targeted cancer drugs showed unprecedented, "clinically meaningful" activity in patients with highly malignant brain tumors that carried a rare genetic mutation, according to a clinical trial report by investigators from Dana-Farber Cancer Institute.
The observation that males evolve more quickly than females has been around since 19th century biologist Charles Darwin noted the majesty of a peacock's tail feather in comparison with the plainness of the peahen's.
Data released today by Standard & Poor's for the S&P Healthcare Economic Composite Index indicate that the average per capita cost of healthcare services covered by commercial insurance and Medicare programs increased by 6.29% over the 12-months ending January 2011.
The American Association for the Study of Liver Diseases, in partnership with the Infectious Diseases Society of America and in collaboration with the International Antiviral Society-USA, created online Recommendations for Testing, Managing, and Treating Hepatitis C in 2014 to aid practitioners treating patients infected with hepatitis C virus (HCV).
NewLink Genetics Corporation today announced positive Phase 2 clinical trial data of its HyperAcute®-Pancreas cancer immunotherapy combined with standard adjuvant chemotherapy in patients with surgically resectable pancreatic cancer. The study results suggest a potentially longer disease-free survival and one-year overall survival in this patient group than reported in previous studies of surgery and adjuvant therapy alone. These data were presented in a poster session at the American Society of Clinical Oncology (ASCO) annual meeting.
› Verified 6 days ago
| Entity Name | Burgess Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538234232 PECOS PAC ID: 0143131516 Enrollment ID: O20031219000549 |
News Archive
A combination of two targeted cancer drugs showed unprecedented, "clinically meaningful" activity in patients with highly malignant brain tumors that carried a rare genetic mutation, according to a clinical trial report by investigators from Dana-Farber Cancer Institute.
The observation that males evolve more quickly than females has been around since 19th century biologist Charles Darwin noted the majesty of a peacock's tail feather in comparison with the plainness of the peahen's.
Data released today by Standard & Poor's for the S&P Healthcare Economic Composite Index indicate that the average per capita cost of healthcare services covered by commercial insurance and Medicare programs increased by 6.29% over the 12-months ending January 2011.
The American Association for the Study of Liver Diseases, in partnership with the Infectious Diseases Society of America and in collaboration with the International Antiviral Society-USA, created online Recommendations for Testing, Managing, and Treating Hepatitis C in 2014 to aid practitioners treating patients infected with hepatitis C virus (HCV).
NewLink Genetics Corporation today announced positive Phase 2 clinical trial data of its HyperAcute®-Pancreas cancer immunotherapy combined with standard adjuvant chemotherapy in patients with surgically resectable pancreatic cancer. The study results suggest a potentially longer disease-free survival and one-year overall survival in this patient group than reported in previous studies of surgery and adjuvant therapy alone. These data were presented in a poster session at the American Society of Clinical Oncology (ASCO) annual meeting.
› Verified 6 days ago
| Entity Name | Family Medicine Clinic, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386824787 PECOS PAC ID: 0547159824 Enrollment ID: O20040313000752 |
News Archive
A combination of two targeted cancer drugs showed unprecedented, "clinically meaningful" activity in patients with highly malignant brain tumors that carried a rare genetic mutation, according to a clinical trial report by investigators from Dana-Farber Cancer Institute.
The observation that males evolve more quickly than females has been around since 19th century biologist Charles Darwin noted the majesty of a peacock's tail feather in comparison with the plainness of the peahen's.
Data released today by Standard & Poor's for the S&P Healthcare Economic Composite Index indicate that the average per capita cost of healthcare services covered by commercial insurance and Medicare programs increased by 6.29% over the 12-months ending January 2011.
The American Association for the Study of Liver Diseases, in partnership with the Infectious Diseases Society of America and in collaboration with the International Antiviral Society-USA, created online Recommendations for Testing, Managing, and Treating Hepatitis C in 2014 to aid practitioners treating patients infected with hepatitis C virus (HCV).
NewLink Genetics Corporation today announced positive Phase 2 clinical trial data of its HyperAcute®-Pancreas cancer immunotherapy combined with standard adjuvant chemotherapy in patients with surgically resectable pancreatic cancer. The study results suggest a potentially longer disease-free survival and one-year overall survival in this patient group than reported in previous studies of surgery and adjuvant therapy alone. These data were presented in a poster session at the American Society of Clinical Oncology (ASCO) annual meeting.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brandon L Kovar, MD 1614 Diamond Street Pl, Onawa, IA 51040-1554 Ph: (712) 423-1525 | Brandon L Kovar, MD 1614 Diamond Street Pl, Onawa, IA 51040-1554 Ph: (712) 423-1525 |
News Archive
A combination of two targeted cancer drugs showed unprecedented, "clinically meaningful" activity in patients with highly malignant brain tumors that carried a rare genetic mutation, according to a clinical trial report by investigators from Dana-Farber Cancer Institute.
The observation that males evolve more quickly than females has been around since 19th century biologist Charles Darwin noted the majesty of a peacock's tail feather in comparison with the plainness of the peahen's.
Data released today by Standard & Poor's for the S&P Healthcare Economic Composite Index indicate that the average per capita cost of healthcare services covered by commercial insurance and Medicare programs increased by 6.29% over the 12-months ending January 2011.
The American Association for the Study of Liver Diseases, in partnership with the Infectious Diseases Society of America and in collaboration with the International Antiviral Society-USA, created online Recommendations for Testing, Managing, and Treating Hepatitis C in 2014 to aid practitioners treating patients infected with hepatitis C virus (HCV).
NewLink Genetics Corporation today announced positive Phase 2 clinical trial data of its HyperAcute®-Pancreas cancer immunotherapy combined with standard adjuvant chemotherapy in patients with surgically resectable pancreatic cancer. The study results suggest a potentially longer disease-free survival and one-year overall survival in this patient group than reported in previous studies of surgery and adjuvant therapy alone. These data were presented in a poster session at the American Society of Clinical Oncology (ASCO) annual meeting.
› Verified 6 days ago
Ashraf Adel Samy Gerges, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1600 Diamond St, Onawa, IA 51040 Phone: 712-423-2311 Fax: 712-423-3500 | |
Kathryn Moore, ARNP Family Medicine Medicare: Medicare Enrolled Practice Location: 1614 Diamond Street Pl, Onawa, IA 51040 Phone: 712-423-1525 Fax: 712-423-2528 | |
Tracy L Kahl, D. O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1614 Diamond Street Pl, Onawa, IA 51040 Phone: 712-423-1525 Fax: 712-423-2528 | |
Paul Edward Dudley, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1614 Diamond Street Pl, Onawa, IA 51040 Phone: 712-423-1525 Fax: 712-423-2528 | |
Dr. Shannon Renee Kennedy, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1614 Diamond Street Pl, Onawa, IA 51040 Phone: 712-423-1525 Fax: 712-423-2528 | |
Dr. Peter M. Daher, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Burgess Health Center, 1600 Diamond Ave, Onawa, IA 51040 Phone: 712-423-2311 |